Group One Trading
RPTX

Group One Trading’s Repare Therapeutics RPTX Stock Holding History

Group One Trading’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,800
Closed -$64.5K – 8581
2025
Q4 		$64.5K Sell
24,800
-34,600
-58% -$69.7K ﹤0.01% 5381
2025
Q3 		$105K Buy
59,400
+58,900
+11,780% +$94.3K ﹤0.01% 5305
2025
Q2 		$695 Sell
500
-1,100
-69% -$1.44K ﹤0.01% 7619
2025
Q1 		$1.58K Sell
1,600
-9,100
-85% -$11K ﹤0.01% 7070
2024
Q4 		$14K Buy
+10,700
New +$31.9K ﹤0.01% 5918
2024
Q3 		– Sell
-4,100
Closed -$13.5K – 7267
2024
Q2 		$13.5K Sell
4,100
-6,800
-62% -$24.2K ﹤0.01% 5468
2024
Q1 		$51.3K Buy
10,900
+3,500
+47% +$22.4K ﹤0.01% 4693
2023
Q4 		$54K Buy
7,400
+5,000
+208% +$28K ﹤0.01% 4998
2023
Q3 		$29K Buy
+2,400
New +$24.8K ﹤0.01% 5577

Group One Trading's RPTX Position: Q3 2025 in Review

Group One Trading sold out of Repare Therapeutics (RPTX) in Q3 2025, closing a stake of 5,722 shares — an estimated $9.16K sold.

Group One Trading first reported a position in RPTX in Q2 2022 and held it in 10 quarters. The position peaked at $179K in Q2 2022. 45 funds tracked by Wall St. Rank hold RPTX as of Q3 2025.

  • Group One Trading reported no remaining Repare Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 5,722 Repare Therapeutics shares in Q3 2025, an estimated $9.16K.
  • Group One Trading first reported a position in Repare Therapeutics in Q2 2022 and held it in 10 quarters.
  • Group One Trading's Repare Therapeutics position peaked at $179K in Q2 2022.
  • 45 funds tracked by Wall St. Rank held Repare Therapeutics as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.